← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $830K of Karuna Therapeutics, Inc.

Sold$829,833
$107.38Price
7,728Shares
−38%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Tue, Mar 1. Filed Wed, Mar 2, 12:52 PM ET, during the session. Not investment advice.